- Motley Fool•2 days ago
Here's how Axovant Sciences, Celldex Therapeutics, and Esperion Therapeutics hope to change how doctors treat disease.
- Motley Fool•3 days ago
The Motley Fool co-founder has enjoyed much success in the market, but not even the best investors have a flawless record.
- GlobeNewswire•13 days ago
HAMPTON, N.J., Feb. 13, 2017-- Celldex Therapeutics, Inc. announced today upcoming investor events for February and March.. Anthony Marucci, Co-founder, President and Chief Executive Officer, and Thomas ...
CLDX : Summary for Celldex Therapeutics, Inc. - Yahoo Finance
Celldex Therapeutics, Inc. (CLDX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||3.20 x 200|
|Ask||3.30 x 200|
|Day's Range||3.21 - 3.30|
|52 Week Range||2.85 - 8.75|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-2.51|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|